Return to News >

Britannia Announces Listing to the Frankfurt Stock Exchange

Britannia Announces Listing to the Frankfurt Stock Exchange

Toronto, Ontario–(Newsfile Corp. – March 7, 2022) – Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) (“Britannia” or the “Company”) is pleased to announce that its common shares (“Shares”) have been accepted for listing on the Frankfurt Stock Exchange (“FSE”). The Shares will currently trade under the symbol “L020” (L-Zero-Two-Zero). Regulatory filings and additional information regarding Britannia are available on SEDAR at

The listing of Britannia shares on the FSE represents the first step in the Company’s capital markets strategy to improve access and awareness of the Company’s shares to global investors, in particular in the UK and Europe where the bulk of Britannia’s operations are based.

Peter Shippen, Britannia’s CEO, comments:

“We are pleased to be listed on to the Frankfurt Stock Exchange and trade in Europe where many of our larger competitors command significantly higher trading multiples. As Britannia continues to build out our global product platform and expand our services in new areas, we feel it is important that UK and European investors can confidently and efficiently trade our shares and participate in Britannia’s growth.”

More Here

Get in Touch

Get in touch with our team of professionals and let’s start a conversation.

    Information Request



    Company Name (optional)

    Phone Number (optional)

    Comments (optional)